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Bacteria isolated from bloodstream 
infections at a tertiary care hospital 
in Dar es Salaam, Tanzania – 
antimicrobial resistance of isolates
To the Editor: Retrospective antimicrobial susceptibility profiles 
from bloodstream infection isolates in Tanzania indicated increasing 
antimicrobial resistance to the first-line and inexpensive antimicrobial 
agents.1 Prospective methicillin-resistant Staphylococcus aureus 
(MRSA) or extended-spectrum beta-lactamase (ESBL) screening 
should be accompanied by watching multidrug-resistant (MDR) 
isolates and their susceptibility to first-line antibiotics. MDR isolates 
in local circulation might still turn out to be susceptible to such 
drugs, as was found at Sant Parmanand Hospital, a 140-bed private, 
tertiary care, multidisciplinary hospital in Delhi. From January to 
November 2010, 5 MDR bacteria were isolated from patients with 
serious infections. 
Isolates were identified by their phenotypic and biochemical 
characterisation. The antibiotic susceptibility was tested by disk 
diffusion methods following the Clinical and Laboratory Standards 
Institute (CLSI) criteria. MDR Gram-negative strains were defined 
to be resistant to meropenem, piperacillin-tazobactam, cefepime, 
amoxicillin-clavulanic acid and amikacin. The 5 MDR Klebsiella 
pneumoniae from 1 133 isolates were isolated from urine in 3 patients 
and from purulent material in 2. Isolates identified included K. 
pneumoniae (468), Escherichia coli (413), Salmonella typhi/paratyphi 
A, B group (32), S. aureus (110), S. citreus (2), Pseudomonas 
aeruginosa (106) and Proteus spp. (2). All 3 MDR isolates from urine 
were susceptible to tigecycline, 2 to ciprofloxacin and 1 each to 
ofloxacin or rifampicin. Both MDR isolates from purulent materials 
were susceptible to tigecycline, ofloxacin and chloramphenicol, while 
1 each was susceptible to aztroenam or rifampicin. 
An annual rather than a 5-year update1 on local antibiotic 
susceptibility profiles would be useful for clinicians, who would be 
able to refer to the previous local antimicrobial susceptibility pattern 
during pilot antibiotic prescription for their patients. This would be 
useful before results of in vitro susceptibility of isolates are available. 
For example, the first-line, inexpensive antimicrobials1 that were 
developed in the 1940s and 1950s would not be the initial choice 
among clinicians managing patients with severe MDR. However, they 
might be the only option available in some cases, even if the in vitro 
susceptibility profiles are dismal.1 
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Dr S Moyo replies: Our 5-year retrospective analysis was aimed at 
establishing the aetiological agents and their antimicrobial resistance 
patterns. We established that MRSA and ESBL were also of public 
health importance in our settings. Since it was a retrospective 
analysis we could not investigate for MDR. We have recently 
shown a high prevalence of ESBL-producing E. coli and Klebsiella 
spp. strains from urine samples, and most of the ESBL-producing 
isolates were MDR, limiting available therapeutic choices.1 We are 
currently conducting another prospective study to monitor the trends 
of MRSA and to determine the presence of MDR. These results, 
together with the previous ones, will guide antimicrobial prescribing 
practice by our clinicians. MDR bacteria may be susceptible to 
the first-line antibiotics, but this was not apparent in our study. In 
vitro susceptibility results may not necessarily reflect what would 
happen in vivo. Our view is that when managing patients with severe 
infections due to MDR organisms, the first-line antibiotics should 
not be used in order to reduce morbidity and mortality that could be 
associated with life-threatening infections. In tertiary hospitals like 
ours or the authors’, first-line antibiotics might not be the only option 
available for management of such cases, as suggested.
Tonsillectomy practice in South Africa
To the Editor: Tonsillectomy is a very common operation done 
by ENT surgeons and general practitioners in South Africa. Our 
impression is that the procedure and its peri-operative care vary 
greatly. We conducted a web-based survey (approved by the UCT 
ethics committee) to evaluate tonsillectomy practice among South 
African ENT surgeons and discuss the findings in relation to 
evidence-based practice from the literature. We report only on the 
controversial and interesting aspects. Ninety-three surgeons (27% of 
the ENT surgeons in active practice in South Africa) completed the 
survey, of whom 65 were in private practice.
Method of tonsillectomy. Sixty per cent of both public and 
state surgeons remove tonsils by conventional cold steel dissection, 
which has a lower bleeding rate than more recent techniques such as 
coblation and bipolar dissection.1
Corticosteroids. Forty-seven per cent of surgeons use peri-
operative steroids. A Cochrane Library report includes Grade A 
supporting evidence that a single intravenous dose of dexamethasone 
is effective, relatively safe and inexpensive in reducing morbidity 
(pain, nausea and vomiting).2
Antibiotics. Sixty per cent of surgeons prescribe antibiotics, of 
whom 42% prescribe amoxicillin/clavulanic acid (Augmentin) and 
38% amoxicillin. Although many surgeons believe these prevent 
postoperative bleeding, this is not supported by the literature.3
Local anaesthesia. Seventeen per cent of surgeons inject the 
tonsil bed with local anaesthetic. Although not believed to benefit 
postoperative pain, the latest systematic review seems to show a 
modest reduction in postoperative pain, and we suggest it as an 
adjunct to the normal analgesia.4
Postoperative pain. Tonsillectomy patients experience a great 
deal of pain. The mean time for cessation of pain is 11 days;5 most 
surgeons (80%) agreed with this. Eighty-nine per cent of respondents 
warned their patients about the 5 - 6-day ‘dip’, when patients typically 
called their surgeon and reported that pain had increased, and 
that they couldn’t eat, had become pyrexial and wished to visit the 
surgeon. There is only one report about this ‘dip’, in the journal Pain, 
which simply stated that pain declines after 3 days, but that 30% of the 
sample population made an unscheduled stop at the doctor between 
days 4 and 7.6
Postoperative chewing gum. Forty-nine per cent of surgeons 
advised patients to chew gum to reduce masseter muscle spasm 
and relieve pain. Only one study could be found that addressed this 
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issue, which reported that chewing gum increased pain and that 
resumption of a normal diet was delayed.7
Postoperative diet. This created the most debate in the survey. 
Thirty per cent of surgeons prescribed a ‘normal’ diet, and the 
remainder advised diets ranging around chips, Nik Naks-type snacks, 
avocados, pawpaws (Natal graduates) and biltong (particularly 
Gauteng graduates); others advised patients to avoid ‘acidic’ foods, 
bananas and fruit juices. Reasons for prescribing the particular diets 
included ‘experience’; ‘patients must eat to prevent bleeding’; ‘hard 
things get stuck in the tonsil bed’; and ‘acid burns the tonsil bed’. No 
publications could be found relating to dietary advice.
Tonsillectomy is a commonly performed operation, and has 
significant morbidity relating to pain, yet peri- and postoperative 
pain management practices vary considerably, with little evidence 
to support some of these practices. Cold steel dissection and intra-
operative steroids can be recommended, based on our literature 
review.
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Cultural safety and family medicine in 
Africa
To the Editor: It took 3 continents and 11 years post-qualification for 
me to realise that Western medicine’s approach to improving health 
care in Africa may be flawed. The realisation occurred as a result 
of reading Belfrage’s experiences of working within the Aborigine 
community in terra nullius (Australia’s vast inhabited interior) and 
seeing how, as a doctor of European descent, she and her culture, 
and the local Aborigines (Alyawarr) and their culture, perceived the 
world in fundamentally different ways. 1
I was born in Europe, raised in southern Africa where I studied 
and worked, decided to further my education abroad, and now reside 
in Melbourne, Australia. My aim has always been to return to Africa 
and implement the skills I now have.
Family medicine in Africa differs from that in Europe in that it is 
generally regarded as not the first point of care, usually takes place in 
a district or teaching hospital, and often requires considerable surgical 
expertise in a resource-poor environment. However, both approaches 
aim to provide comprehensive and compassionate generalist services 
within a community context.
Western-trained doctors believe in the scientific approach and 
disbelieve the supernatural or the anecdotal. We believe in the 
germ theory of many diseases. A doctor’s work is linear – history, 
examination, investigation, diagnosis, treatment. Doctors expect 
patients to believe and share their world view and act on their 
advice.
‘Cultural safety’ is quite different for each approach. This concept was 
developed in the 1980s in New Zealand in response to the indigenous 
Maori people’s discontent with nursing care. Maori nursing students 
and the work of I M Ramsden supported ‘cultural safety’, which 
upheld political ideas of self-determination and de-colonisation of 
Maori people;2 it goes beyond ethnocultural practices, political views 
or being culturally aware or sensitive. Ramsden and others view these 
latter terms as a learning process continuum: cultural awareness 
is the starting point involving the understanding of differences; 
cultural sensitivity is intermediate where self-exploration begins; 
and cultural safety is the final outcome.
Rather than emphasising learning about other peoples’ diverse 
cultures, cultural safety requires practitioners to identify their own 
values, beliefs and assumptions that guide their thinking and actions, 
and then to engage in practice that reflects an understanding and 
respect for what the patient and family believe is important to 
healing, health and well-being.3 Health practitioners cannot assume 
that they provide culturally safe care, as only the recipient of care can 
assess the level of risk or safety that they experience. Cultural safety 
questions the dictum of ‘treating everyone the same’ regardless of age, 
ethnicity or gender. A central tenet of cultural safety is that people 
receiving the care decide what is culturally safe or unsafe, enabling 
them to believe that the health care is connected to their lives. They 
are involved and have choices that are not primarily part of someone 
else’s agenda. Cultural safety is often more concerned with not 
disempowering people than with empowering them.   
Whether family medicine in Africa should adopt this concept 
in clinical care and teaching needs to be explored. Culturally safe, 
or appropriate, programmes enhance personal empowerment, so 
promoting more effective health care service delivery for African 
people.
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